A comparison of reproductive risk factors for CIS lesions and invasive breast cancer

International Journal of Cancer

Volumn 108, Issue 5, 2004, Pages 750-753

  Wohlfahrt, Jan ^a   Rank, Fritz ^b   Kroman, Niels ^b   Melbye, Mads ^a,c  

^a DEPARTMENT OF EPIDEMIOLOGY RESEARCH   (Denmark)

^b International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

^c STATENS SERUM INSTITUT   (Denmark)

Author keywords

Breast cancer; Carcinoma in situ; Disease progression; Reproductive history

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CARCINOMA IN SITU; COHORT ANALYSIS; COMPARATIVE STUDY; DENMARK; DISEASE COURSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PARITY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

ADOLESCENT; ADULT; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CARCINOMA, LOBULAR; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; REPRODUCTIVE HISTORY; RISK FACTORS;

EID: 0346655245     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.11588     Document Type: Article

References (25)

1. Bodian CA. Benign breast diseases, carcinoma in situ, and breast cancer risk. Epidemiol Rev 1993;15:177-87.
2. Holzman D. Scientists show that invasive breast cancer develops from early cancer cells. J Natl Cancer Inst 1995;87:710-1.
3. Silverstein MJ. Ductal carcinoma in situ of the breast. BMJ 1998;317:734-9.
4. Melbye M, Wohlfahrt J, Olsen JH, Frisch M, Westergaard T, Helweg-Larsen K, Andersen PK. Induced abortion and the risk of breast cancer. N Engl J Med 1997;336:81-5.
5. Westergaard T, Wohlfahrt J, Aaby P, Melbye M. Population based study of rates of multiple pregnancies in Denmark, 1980-94. BMJ 1997;314:775-9.
6. Andersen KW, Mouridsen HT. Danish breast cancer cooperative group (DBCG). A description of the register of the nation-wide programme for primary breast cancer. Acta Oncol 1988;27:627-47.
7. Kroman N, Wohlfahrt J, Andersen KW, Mouridsen HT, Westergaard T, Melbye M. Time since childbirth and prognosis in primary breast cancer: population based study. BMJ 1997;315:851-5.
8. Storm HH. The Danish cancer registry, a self-reporting national cancer registration system with elements of active data collection. IARC Sci Publ 1991;220-36.
9. Andersen JA, Nielsen M, Blichert-Toft M. The growth pattern of in situ carcinoma in the female breast. Acta Oncol 1988;27:739-43.
10. Holland R, Peterse JL, Millis RR, Eusebi V, Faverly D, van de Vijver MJ, Zafrani B. Ductal carcinoma in situ: a proposal for a new classification. Semin Diagn Pathol 1994;11:167-80.
11. Ottesen GL, Graversen HP, Blichert-Toft M, Christensen IJ, Andersen JA. Carcinoma in situ of the female breast. 10 year follow-up results of a prospective nationwide study. Breast Cancer Res Treat 2000 Aug;62(3):197-210 2000;62:197-210.
12. Ottesen GL, Graversen HP, Blichert-Toft M, Christensen IJ, Andersen JA. Carcinoma in situ of the female breast. 10 year follow-up results of a prospective nationwide study. Breast Cancer Res Treat 2000 Aug;62(3):197-210 2000;62:197-210.
13. Njor SH, Olsen AH, Bellstrøm T, Dyreborg U, Bak M, Axelsson C, Graversen HP, Schwartz W, Lynge E. Mammography screening in the county of Fyn November 1993-December 1999. APMIS(Suppl) 2003;110:1-33.
14. Greenland S. Dose-response and trend analysis in epidemiology: alternatives to categorical analysis. Epidemiology 1995;6:356-65.
15. Wohlfahrt J, Andersen PK, Melbye M. Multivariate competing risks. Stat Med 1999;18:1023-30.
16. Greenland S, Longnecker MP. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol 1992;135:1301-9.
17. Wohlfahrt J, Melbye M. Age at any birth is associated with breast cancer risk. Epidemiology 2001;12:68-73.
18. Lynge E. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography screening evaluation group. APMIS(Suppl) 1998;83:1-44.
19. Trentham-Dietz A, Newcomb PA, Storer BE, Remington PL. Risk factors for carcinoma in situ of the breast. Cancer Epidemiol Biomarkers Prev 2000;9:697-703.
20. Brinton LA, Hoover R, Fraumeni Jr JF,. Epidemiology of minimal breast cancer. JAMA 1983;249:483-7.
21. Weiss HA, Brinton LA, Brogan D, Coates RJ, Gammon MD, Malone KE, Schoenberg JB, Swanson CA. Epidemiology of in situ and invasive breast cancer in women aged under 45. Br J Cancer 1996;73:1298-305.
22. Wohlfahrt J, Andersen PK, Mouridsen HT, Adami HO, Melbye M. Reproductive history and stage of breast cancer. Am J Epidemiol 1999;150:1325-30.
23. Wohlfahrt J, Andersen PK, Mouridsen HT, Melbye M. Risk of late-stage breast cancer after a childbirth. Am J Epidemiol 2001;153:1079-84.
24. Giri DD, Dundas SA, Nottingham JF, Underwood JC. Oestrogen receptors in benign epithelial lesions and intraduct carcinomas of the breast: an immunohistological study. Histopathology 1989;15:575-84.
25. Fisher ER, Costantino J, Fisher B, Palekar AS, Paik SM, Suarez CM, Wolmark N. Pathologic findings from the National surgical adjuvant breast project (NSABP) protocol B-17. Five-year observations concerning lobular carcinoma in situ. Cancer 1996;78:1403-16.